Achieve Life Sciences, Inc. Shareholders' Equity
Achieve Life Sciences, Inc. (ACHV) had Shareholders' Equity of -$14.68 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent -$14.68M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.68M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $21.52M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $33.62M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$14.68M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $10.68M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $21.52M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $33.62M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $41.67M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $10.28M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $20.90M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $31.38M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $42.28M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $49.46M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | -$1.45M 10-K · filed 2026-03-24 | |
| 2023-09-30 | $4.04M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $9.70M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $443.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $8.30M 10-K · filed 2026-03-24 | |
| 2022-09-30 | $1.04M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $13.17M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $21.43M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $28.04M 10-K · filed 2025-03-11 | |
| 2021-09-30 | $34.70M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $40.85M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $30.09M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $37.29M 10-K · filed 2024-03-28 | |
| 2020-09-30 | $25.68M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $14.54M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $14.98M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $18.05M 10-K · filed 2023-03-16 | |
| 2019-09-30 | $8.14M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $11.50M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $10.19M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $15.80M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $14.16M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $16.44M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $6.14M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $15.80M 10-K · filed 2022-03-10 | $7.88M 10-K · filed 2018-03-01 |
| 2017-09-30 | $10.68M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $13.10M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $15.89M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $610.00K 10-K · filed 2020-03-13 | $18.97M 10-K · filed 2017-02-23 |
| 2016-09-30 | $24.42M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $28.25M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $34.22M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.84M 10-K · filed 2019-03-14 | $37.44M 10-K · filed 2016-03-09 |
| 2015-09-30 | $38.77M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $28.19M 10-Q · filed 2015-08-13 | |
| 2015-05-12 | $0.00 10-K · filed 2018-03-01 | |
| 2015-03-31 | $30.02M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $34.06M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $38.85M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $26.46M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $29.60M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $37.21M 10-K · filed 2017-02-23 | |
| 2013-09-30 | $43.54M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $52.69M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $60.27M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $66.21M 10-K · filed 2016-03-09 | |
| 2012-09-30 | $69.76M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $74.72M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $78.13M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $30.89M 10-K · filed 2015-03-26 | |
| 2011-09-30 | $40.02M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $35.20M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $44.13M 10-K · filed 2014-03-11 | |
| 2009-12-31 | $22.96M 10-K · filed 2013-03-07 | |
| 2008-12-31 | $10.71M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |